- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 261/08 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 261/08
Total number of patents in this class: 732
10-year publication summary
|
61
|
50
|
66
|
61
|
59
|
59
|
58
|
47
|
40
|
4
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
31 |
| Novartis AG | 11238 |
15 |
| Enanta Pharmaceuticals, Inc. | 420 |
15 |
| Bayer Cropscience AG | 2241 |
12 |
| AstraZeneca AB | 3042 |
11 |
| Abbvie Inc. | 1808 |
11 |
| Takeda Pharmaceutical Company Limited | 2961 |
10 |
| Gilead Sciences, Inc. | 1879 |
10 |
| Janssen Pharmaceutica N.V. | 3839 |
9 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
9 |
| Calico Life Sciences LLC | 71 |
9 |
| BASF SE | 19740 |
8 |
| Amgen Inc. | 3779 |
8 |
| Vectus Biosystems Limited | 36 |
7 |
| H. Lundbeck A/S | 1252 |
7 |
| NMD Pharma A/S | 32 |
7 |
| F. Hoffmann-La Roche AG | 7958 |
6 |
| Amira Pharmaceuticals, Inc. | 70 |
6 |
| Canopy Growth Corporation | 270 |
6 |
| Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1657 |
6 |
| Other owners | 529 |